Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells

Takanori Shouda, Koji Hiraoka, Setsuro Komiya, Tetsuya Hamada, Michihisa Zenmyo, Hiroshi Iwasaki, Teruto Isayama, Nobuhiro Fukushima, Kensei Nagata, Akihiko Yoshimura

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

There is no established optimum treatment for malignant fibrous histiocytoma (MFH) at present, and few MFH cell lines are established. In the present study, we established new MFH cell lines, KHZ-MFH and SFT85-03, and investigated the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway. We found that MFH cells secreted high levels of IL-6 and that STAT3 was constitutively activated in these cells. The JAK2 kinase inhibitor, tyrphostin AG490, suppressed the growth of MFH cells and inhibited the secretion of IL-6. Furthermore, blockade of activated STAT3 by forced expression of a cytokine signaling repressor, SOCS3 gene as well as a dominant-negative STAT3 in these cells significantly suppressed their growth. These results indicated that an autocrine mechanism of the JAK/STAT3 signaling pathway could promote the growth of MFH cells and that this pathway could be a therapeutic target of MFH.

Original languageEnglish
Pages (from-to)176-184
Number of pages9
JournalCancer Letters
Volume231
Issue number2
DOIs
Publication statusPublished - 2006 Jan 18
Externally publishedYes

Fingerprint

Malignant Fibrous Histiocytoma
Interleukin-6
Neoplasms
Growth
Tyrphostins
Janus Kinases
Cell Line
Transducers
Phosphotransferases
Cytokines

Keywords

  • Malignant fibrous histiocytoma
  • RT-PCR
  • Tumor cells

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. / Shouda, Takanori; Hiraoka, Koji; Komiya, Setsuro; Hamada, Tetsuya; Zenmyo, Michihisa; Iwasaki, Hiroshi; Isayama, Teruto; Fukushima, Nobuhiro; Nagata, Kensei; Yoshimura, Akihiko.

In: Cancer Letters, Vol. 231, No. 2, 18.01.2006, p. 176-184.

Research output: Contribution to journalArticle

Shouda, T, Hiraoka, K, Komiya, S, Hamada, T, Zenmyo, M, Iwasaki, H, Isayama, T, Fukushima, N, Nagata, K & Yoshimura, A 2006, 'Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells', Cancer Letters, vol. 231, no. 2, pp. 176-184. https://doi.org/10.1016/j.canlet.2005.01.042
Shouda, Takanori ; Hiraoka, Koji ; Komiya, Setsuro ; Hamada, Tetsuya ; Zenmyo, Michihisa ; Iwasaki, Hiroshi ; Isayama, Teruto ; Fukushima, Nobuhiro ; Nagata, Kensei ; Yoshimura, Akihiko. / Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. In: Cancer Letters. 2006 ; Vol. 231, No. 2. pp. 176-184.
@article{2edd9183b8104ca1a595fc69b520ed55,
title = "Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells",
abstract = "There is no established optimum treatment for malignant fibrous histiocytoma (MFH) at present, and few MFH cell lines are established. In the present study, we established new MFH cell lines, KHZ-MFH and SFT85-03, and investigated the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway. We found that MFH cells secreted high levels of IL-6 and that STAT3 was constitutively activated in these cells. The JAK2 kinase inhibitor, tyrphostin AG490, suppressed the growth of MFH cells and inhibited the secretion of IL-6. Furthermore, blockade of activated STAT3 by forced expression of a cytokine signaling repressor, SOCS3 gene as well as a dominant-negative STAT3 in these cells significantly suppressed their growth. These results indicated that an autocrine mechanism of the JAK/STAT3 signaling pathway could promote the growth of MFH cells and that this pathway could be a therapeutic target of MFH.",
keywords = "Malignant fibrous histiocytoma, RT-PCR, Tumor cells",
author = "Takanori Shouda and Koji Hiraoka and Setsuro Komiya and Tetsuya Hamada and Michihisa Zenmyo and Hiroshi Iwasaki and Teruto Isayama and Nobuhiro Fukushima and Kensei Nagata and Akihiko Yoshimura",
year = "2006",
month = "1",
day = "18",
doi = "10.1016/j.canlet.2005.01.042",
language = "English",
volume = "231",
pages = "176--184",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells

AU - Shouda, Takanori

AU - Hiraoka, Koji

AU - Komiya, Setsuro

AU - Hamada, Tetsuya

AU - Zenmyo, Michihisa

AU - Iwasaki, Hiroshi

AU - Isayama, Teruto

AU - Fukushima, Nobuhiro

AU - Nagata, Kensei

AU - Yoshimura, Akihiko

PY - 2006/1/18

Y1 - 2006/1/18

N2 - There is no established optimum treatment for malignant fibrous histiocytoma (MFH) at present, and few MFH cell lines are established. In the present study, we established new MFH cell lines, KHZ-MFH and SFT85-03, and investigated the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway. We found that MFH cells secreted high levels of IL-6 and that STAT3 was constitutively activated in these cells. The JAK2 kinase inhibitor, tyrphostin AG490, suppressed the growth of MFH cells and inhibited the secretion of IL-6. Furthermore, blockade of activated STAT3 by forced expression of a cytokine signaling repressor, SOCS3 gene as well as a dominant-negative STAT3 in these cells significantly suppressed their growth. These results indicated that an autocrine mechanism of the JAK/STAT3 signaling pathway could promote the growth of MFH cells and that this pathway could be a therapeutic target of MFH.

AB - There is no established optimum treatment for malignant fibrous histiocytoma (MFH) at present, and few MFH cell lines are established. In the present study, we established new MFH cell lines, KHZ-MFH and SFT85-03, and investigated the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway. We found that MFH cells secreted high levels of IL-6 and that STAT3 was constitutively activated in these cells. The JAK2 kinase inhibitor, tyrphostin AG490, suppressed the growth of MFH cells and inhibited the secretion of IL-6. Furthermore, blockade of activated STAT3 by forced expression of a cytokine signaling repressor, SOCS3 gene as well as a dominant-negative STAT3 in these cells significantly suppressed their growth. These results indicated that an autocrine mechanism of the JAK/STAT3 signaling pathway could promote the growth of MFH cells and that this pathway could be a therapeutic target of MFH.

KW - Malignant fibrous histiocytoma

KW - RT-PCR

KW - Tumor cells

UR - http://www.scopus.com/inward/record.url?scp=29844433086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29844433086&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2005.01.042

DO - 10.1016/j.canlet.2005.01.042

M3 - Article

C2 - 16399222

AN - SCOPUS:29844433086

VL - 231

SP - 176

EP - 184

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -